Promomed: Radamine Viro (a drug to protect against viral and bacterial infections)

2022: Obtaining a patent

As part of joint work with the Center for the Promotion of Advanced Technologies, the Promomed group of companies received three patents at once for their own developments in an accelerated mode. The company announced this on October 26, 2022.

Radamine Viro manufactured by Promomed is a special drug of its kind due to its mechanism of action. The active substance of the drug - RNA double-stranded sodium salt, stimulates the production of all the main types of interferons, triggering an adequate innate and adaptive immune response, which ensures the rapid onset of a therapeutic effect and the protection of the body from various viral and bacterial infections.

Expanding the area of ​ ​ research interest beyond chemical synthesis and turning to biotechnology, the specialists of the Promomed group were able not only to create their first biotechnological drug, but also to develop a special technology for the production and purification of the product.

To patent its inventions, the company used the program of the Center for the Promotion of Advanced Technologies, launched on the basis of Rospatent. As part of joint work with the department, the Promomed group of companies received not only assistance in complex patenting of developments, but also the possibility of obtaining security documents for their developments in fasttrek mode.

The result of such a collaboration was three Russian patents in pharmaceuticals at once. They provide legal protection for an RNA-based antiviral drug for the prevention and treatment of coronavirus infection and methods for obtaining its components. The drug is completely domestic. Its innovation consists in a quick immune response, which occurs 2-6 hours after the use of the drug and provides a natural protective reaction of the body, - said the head of Rospatent Yuri Zubov.

The support program implemented by the Assistance Center is completely based on the norms of the current legislation and does not violate the protected rights of other patents, including foreign ones.

The activities of the Assistance Center are the very long-awaited tool from Rospatent that pharmaceutical manufacturers needed to protect innovative solutions and comfortable work on the Russian market. Thanks to the fasttrek, three patents for our biotech drug Radamin Viro have already been received in a short time, and I can say with confidence that this algorithm works, it is effective and really allows you to quickly resolve issues of protecting the interests of developers, - said the Head of the Board of Directors of Promomed Group of Companies Pyotr Beliy.

See also

• Viruses